MyDesk virtual desktop maintenance set for March 16
vDesktop service will be unavailable 8-11 p.m., Thursday, Mar. 16
MyDesk virtual desktop (vDesktop) service, including remote access to many of the software options available in on-campus computer labs, will be unavailable from 8 p.m. to 11 p.m., Thursday, Mar. 16, during a planned maintenance window. The update will improve virtual desktop performance, reliability, and security.
What you can expect
vDesktop connections through the VMware Horizon desktop client or HTML web client will not be available from 8 p.m. to 11 p.m., Thursday, Mar. 16.
- Students, faculty, and staff will not be able to start a new MyDesk vDesktop session during the planned maintenance window.
- Sessions already in progress may get disconnected between 8 and 11 p.m.
- You will be able to access MyDesk virtual desktops after the maintenance window ends.
Technical help and support
If you experience any issues following this maintenance window, please contact the IT Service Desk.
- Submit a ticket.
- Or call us.
- From your personal phone, dial 513-556-HELP (4357) or 866-397-3382; select option 2.
- From a university phone on campus, dial 6-HELP (4357); select option 2.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.